Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.

MLA

Matchett, William E., et al. “Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.” Journal of Immunology (Baltimore, Md. : 1950), vol. 207, no. 2, July 2021, pp. 376–79. EBSCOhost, https://doi.org/10.4049/jimmunol.2100421.

APA

Matchett, W. E., Joag, V., Stolley, J. M., Shepherd, F. K., Quarnstrom, C. F., Mickelson, C. K., Wijeyesinghe, S., Soerens, A. G., Becker, S., Thiede, J. M., Weyu, E., O’Flanagan, S. D., Walter, J. A., Vu, M. N., Menachery, V. D., Bold, T. D., Vezys, V., Jenkins, M. K., Langlois, R. A., & Masopust, D. (2021). Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity. Journal of Immunology (Baltimore, Md. : 1950), 207(2), 376–379. https://doi.org/10.4049/jimmunol.2100421

Chicago

Matchett, William E, Vineet Joag, J Michael Stolley, Frances K Shepherd, Clare F Quarnstrom, Clayton K Mickelson, Sathi Wijeyesinghe, et al. 2021. “Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity.” Journal of Immunology (Baltimore, Md. : 1950) 207 (2): 376–79. doi:10.4049/jimmunol.2100421.